{"transactions":[{"id":748751,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-06T00:09:02.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":16875,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting."}],"balance_after":42098,"source":{"system":"sec-edgar","filing":"0001193125-26-260259","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000119312526260259/ownership.xml","form_type":"4"}},{"id":1213610,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2025-03-12T00:00:11.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":4792,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4792,"derivative":{"exercise_price":99.69,"exercise_date":"2026-03-10","expiration_date":"2035-03-10","underlying":"Common Stock","underlying_shares":4792},"source":{"system":"sec-edgar","filing":"0000950170-25-037526","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037526/ownership.xml","form_type":"4"}},{"id":1213609,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-12T00:00:11.000Z","date":"2025-03-10","kind":"grant","planned":false,"acquired":true,"shares":2383,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 10, 2026."}],"balance_after":25223,"source":{"system":"sec-edgar","filing":"0000950170-25-037526","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017025037526/ownership.xml","form_type":"4"}},{"id":1331458,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (right to buy)","published_at":"2024-12-17T01:00:03.000Z","date":"2024-12-12","kind":"exercise","planned":false,"acquired":false,"shares":10500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.71,"exercise_date":"2017-02-28","expiration_date":"2026-02-28","underlying":"Common Stock","underlying_shares":10500},"source":{"system":"sec-edgar","filing":"0000950170-24-136847","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024136847/ownership.xml","form_type":"4"}},{"id":1331457,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T01:00:03.000Z","date":"2024-12-12","kind":"sale","planned":false,"acquired":false,"shares":10500,"price":124.84,"value":1310820.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.92 to $124.80, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":22840,"source":{"system":"sec-edgar","filing":"0000950170-24-136847","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024136847/ownership.xml","form_type":"4"}},{"id":1331456,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-12-17T01:00:03.000Z","date":"2024-12-12","kind":"exercise","planned":false,"acquired":true,"shares":10500,"price":13.71,"value":143955.0,"ownership":{"direct":true},"balance_after":33340,"source":{"system":"sec-edgar","filing":"0000950170-24-136847","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024136847/ownership.xml","form_type":"4"}},{"id":1585310,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-12T00:02:32.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":13.9,"exercise_date":"2016-02-27","expiration_date":"2035-02-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000950170-24-029536","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/ownership.xml","form_type":"4"}},{"id":1585309,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T00:02:32.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":100,"price":122.39,"value":12239.0,"ownership":{"direct":true},"balance_after":22840,"source":{"system":"sec-edgar","filing":"0000950170-24-029536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/ownership.xml","form_type":"4"}},{"id":1585308,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T00:02:32.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":11745,"price":123.1,"value":1445809.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $122.65 to $123.58, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":22940,"source":{"system":"sec-edgar","filing":"0000950170-24-029536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/ownership.xml","form_type":"4"}},{"id":1585307,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T00:02:32.000Z","date":"2024-03-08","kind":"sale","planned":false,"acquired":false,"shares":3155,"price":123.85,"value":390746.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $123.6 to $124.6, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above."}],"balance_after":34685,"source":{"system":"sec-edgar","filing":"0000950170-24-029536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/ownership.xml","form_type":"4"}},{"id":1585306,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-12T00:02:32.000Z","date":"2024-03-08","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":13.9,"value":208500.0,"ownership":{"direct":true},"balance_after":37840,"source":{"system":"sec-edgar","filing":"0000950170-24-029536","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024029536/ownership.xml","form_type":"4"}},{"id":1599792,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-06T01:00:30.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":3679,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3679,"derivative":{"exercise_price":128.67,"exercise_date":"2025-03-01","expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":3679},"source":{"system":"sec-edgar","filing":"0000950170-24-026619","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026619/ownership.xml","form_type":"4"}},{"id":1599791,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-03-06T01:00:30.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":1846,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 1, 2025."}],"balance_after":22840,"source":{"system":"sec-edgar","filing":"0000950170-24-026619","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000095017024026619/ownership.xml","form_type":"4"}},{"id":1813396,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-09T00:00:06.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":29.03,"exercise_date":"2015-02-28","expiration_date":"2024-02-28","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001209191-23-045095","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123045095/doc4.xml","form_type":"4"}},{"id":1813395,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-09T00:00:06.000Z","date":"2023-08-04","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":106.72,"value":1600800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.42 to $107.04 per share. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the ranges set forth above."}],"balance_after":20994,"source":{"system":"sec-edgar","filing":"0001209191-23-045095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123045095/doc4.xml","form_type":"4"}},{"id":1813394,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-09T00:00:06.000Z","date":"2023-08-04","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":29.03,"value":435450.0,"ownership":{"direct":true},"balance_after":35994,"source":{"system":"sec-edgar","filing":"0001209191-23-045095","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123045095/doc4.xml","form_type":"4"}},{"id":1964305,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-09T01:01:02.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":3257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3257,"derivative":{"exercise_price":155.99,"exercise_date":"2024-03-06","expiration_date":"2033-03-06","underlying":"Common Stock","underlying_shares":3257},"source":{"system":"sec-edgar","filing":"0001209191-23-017404","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017404/doc4.xml","form_type":"4"}},{"id":1964304,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-09T01:01:02.000Z","date":"2023-03-06","kind":"grant","acquired":true,"shares":1523,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 6, 2024."}],"balance_after":20994,"source":{"system":"sec-edgar","filing":"0001209191-23-017404","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919123017404/doc4.xml","form_type":"4"}},{"id":2345780,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-03-09T01:05:07.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":5077,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5077,"derivative":{"exercise_price":80.42,"exercise_date":"2023-03-07","expiration_date":"2032-03-07","underlying":"Common Stock","underlying_shares":5077},"source":{"system":"sec-edgar","filing":"0001209191-22-017350","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017350/doc4.xml","form_type":"4"}},{"id":2345779,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-09T01:05:07.000Z","date":"2022-03-07","kind":"grant","acquired":true,"shares":2953,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 7, 2023."}],"balance_after":19471,"source":{"system":"sec-edgar","filing":"0001209191-22-017350","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919122017350/doc4.xml","form_type":"4"}},{"id":2798054,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-11T01:03:31.000Z","date":"2021-03-08","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":34.92,"exercise_date":"2014-06-04","expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-019670","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019670/doc4.xml","form_type":"4"}},{"id":2798053,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T01:03:31.000Z","date":"2021-03-08","kind":"sale","acquired":false,"shares":10000,"price":83.51,"value":835100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in transactions at prices ranging from 83.33 to 83.91, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":16518,"source":{"system":"sec-edgar","filing":"0001209191-21-019670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019670/doc4.xml","form_type":"4"}},{"id":2798052,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-11T01:03:31.000Z","date":"2021-03-08","kind":"exercise","acquired":true,"shares":10000,"price":34.92,"value":349200.0,"ownership":{"direct":true},"balance_after":26518,"source":{"system":"sec-edgar","filing":"0001209191-21-019670","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121019670/doc4.xml","form_type":"4"}},{"id":2807367,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-06T01:06:19.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":5518,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5518,"derivative":{"exercise_price":87.11,"exercise_date":"2022-03-03","expiration_date":"2031-03-03","underlying":"Common Stock","underlying_shares":5518},"source":{"system":"sec-edgar","filing":"0001209191-21-018423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018423/doc4.xml","form_type":"4"}},{"id":2807366,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-03-06T01:06:19.000Z","date":"2021-03-03","kind":"grant","acquired":true,"shares":2726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on March 3, 2022."}],"balance_after":16518,"source":{"system":"sec-edgar","filing":"0001209191-21-018423","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919121018423/doc4.xml","form_type":"4"}},{"id":3062489,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-08-12T00:00:18.000Z","date":"2020-08-10","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":34.92,"exercise_date":"2014-06-04","expiration_date":"2023-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-046251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120046251/doc4.xml","form_type":"4"}},{"id":3062488,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T00:00:18.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":777,"price":159.65,"value":124048.05,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in transactions at prices ranging from 159.47 to 159.90, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":13792,"source":{"system":"sec-edgar","filing":"0001209191-20-046251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120046251/doc4.xml","form_type":"4"}},{"id":3062487,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T00:00:18.000Z","date":"2020-08-10","kind":"sale","acquired":false,"shares":9223,"price":158.95,"value":1465995.85,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in transactions at prices ranging from 158.45 to 159.36, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":14569,"source":{"system":"sec-edgar","filing":"0001209191-20-046251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120046251/doc4.xml","form_type":"4"}},{"id":3062486,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-12T00:00:18.000Z","date":"2020-08-10","kind":"exercise","acquired":true,"shares":10000,"price":34.92,"value":349200.0,"ownership":{"direct":true},"balance_after":23792,"source":{"system":"sec-edgar","filing":"0001209191-20-046251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120046251/doc4.xml","form_type":"4"}},{"id":3138101,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Oprion (right to buy)","published_at":"2020-05-23T00:00:40.000Z","date":"2020-05-20","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":10.08,"exercise_date":"2013-08-23","expiration_date":"2022-08-23","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-031881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120031881/doc4.xml","form_type":"4"}},{"id":3138100,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:00:40.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":854,"price":151.77,"value":129611.58,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The shares were sold in transactions at prices ranging from $151.67 to $151.75, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":13792,"source":{"system":"sec-edgar","filing":"0001209191-20-031881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120031881/doc4.xml","form_type":"4"}},{"id":3138099,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:00:40.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":2046,"price":151.22,"value":309396.12,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares were sold in transactions at prices ranging from $150.62 to $151.62, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":14646,"source":{"system":"sec-edgar","filing":"0001209191-20-031881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120031881/doc4.xml","form_type":"4"}},{"id":3138098,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:00:40.000Z","date":"2020-05-20","kind":"sale","acquired":false,"shares":2100,"price":149.62,"value":314202.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in transactions at prices ranging from $149.11 to $149.89, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":16692,"source":{"system":"sec-edgar","filing":"0001209191-20-031881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120031881/doc4.xml","form_type":"4"}},{"id":3138097,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-23T00:00:40.000Z","date":"2020-05-20","kind":"exercise","acquired":true,"shares":5000,"price":10.08,"value":50400.0,"ownership":{"direct":true},"balance_after":18792,"source":{"system":"sec-edgar","filing":"0001209191-20-031881","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120031881/doc4.xml","form_type":"4"}},{"id":3223443,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-03-07T01:01:01.000Z","date":"2020-03-04","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":8.46,"exercise_date":"2012-06-21","expiration_date":"2021-06-21","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-017097","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120017097/doc4.xml","form_type":"4"}},{"id":3223442,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-07T01:01:01.000Z","date":"2020-03-04","kind":"sale","acquired":false,"shares":5000,"price":116.89,"value":584450.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were sold in multiple transactions at prices ranging from $116.8104 to $117.305, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein."}],"balance_after":13792,"source":{"system":"sec-edgar","filing":"0001209191-20-017097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120017097/doc4.xml","form_type":"4"}},{"id":3223441,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-07T01:01:01.000Z","date":"2020-03-04","kind":"exercise","acquired":true,"shares":5000,"price":8.46,"value":42300.0,"ownership":{"direct":true},"balance_after":18792,"source":{"system":"sec-edgar","filing":"0001209191-20-017097","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120017097/doc4.xml","form_type":"4"}},{"id":3242233,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-02-29T01:04:59.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":3685,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3685,"derivative":{"exercise_price":114.47,"exercise_date":"2021-02-28","expiration_date":"2030-02-28","underlying":"Common Stock","underlying_shares":3685},"source":{"system":"sec-edgar","filing":"0001209191-20-014233","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014233/doc4.xml","form_type":"4"}},{"id":3242232,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-29T01:04:59.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":2075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents the right to receive one share of common stock. The RSUs will vest in full on February 28, 2021."}],"balance_after":13792,"source":{"system":"sec-edgar","filing":"0001209191-20-014233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919120014233/doc4.xml","form_type":"4"}},{"id":3512615,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-05-25T00:03:10.000Z","date":"2019-05-23","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option to purchase shares is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.8,"expiration_date":"2020-06-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-032833","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119032833/doc4.xml","form_type":"4"}},{"id":3512614,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-25T00:03:10.000Z","date":"2019-05-23","kind":"sale","acquired":false,"shares":10000,"price":120,"value":1200000.0,"ownership":{"direct":true},"balance_after":11717,"source":{"system":"sec-edgar","filing":"0001209191-19-032833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119032833/doc4.xml","form_type":"4"}},{"id":3512613,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-05-25T00:03:10.000Z","date":"2019-05-23","kind":"exercise","acquired":true,"shares":10000,"price":7.8,"value":78000.0,"ownership":{"direct":true},"balance_after":21717,"source":{"system":"sec-edgar","filing":"0001209191-19-032833","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119032833/doc4.xml","form_type":"4"}},{"id":3620935,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-03-05T01:05:50.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":3213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":3213,"derivative":{"exercise_price":145.48,"expiration_date":"2029-03-04","underlying":"Common Stock","underlying_shares":3213},"source":{"system":"sec-edgar","filing":"0001209191-19-016035","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016035/doc4.xml","form_type":"4"}},{"id":3620934,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-05T01:05:50.000Z","date":"2019-03-04","kind":"grant","acquired":true,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2019 Annual Meeting of Stockholders."}],"balance_after":11717,"source":{"system":"sec-edgar","filing":"0001209191-19-016035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919119016035/doc4.xml","form_type":"4"}},{"id":3777401,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-02T22:01:19.000Z","date":"2018-11-01","kind":"exercise","acquired":false,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option to purchase shares is fully vested."}],"balance_after":0,"derivative":{"exercise_price":8.94,"expiration_date":"2020-02-08","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-18-056987","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056987/doc4.xml","form_type":"4"}},{"id":3777400,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T22:01:19.000Z","date":"2018-11-01","kind":"sale","acquired":false,"shares":6667,"price":140.5,"value":936713.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $140.50 to $140.53, inclusive. The reporting person undertakes to provide to Sarepta Therapeutics, Inc., any security holder of Sarepta Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price with the range set forth herein."}],"balance_after":10084,"source":{"system":"sec-edgar","filing":"0001209191-18-056987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056987/doc4.xml","form_type":"4"}},{"id":3777399,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-02T22:01:19.000Z","date":"2018-11-01","kind":"exercise","acquired":true,"shares":6667,"price":8.94,"value":59602.98,"ownership":{"direct":true},"balance_after":16751,"source":{"system":"sec-edgar","filing":"0001209191-18-056987","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118056987/doc4.xml","form_type":"4"}},{"id":4009171,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2018-03-07T23:06:58.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":4820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":4820,"derivative":{"exercise_price":71.45,"expiration_date":"2028-03-05","underlying":"Common Stock","underlying_shares":4820},"source":{"system":"sec-edgar","filing":"0001209191-18-017795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017795/doc4.xml","form_type":"4"}},{"id":4009170,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-07T23:06:58.000Z","date":"2018-03-05","kind":"grant","acquired":true,"shares":3418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock award represents the right to receive one share of common stock and will vest in full on the first year anniversary of the Issuer's 2018 Annual Meeting of Stockholders."}],"balance_after":10084,"source":{"system":"sec-edgar","filing":"0001209191-18-017795","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919118017795/doc4.xml","form_type":"4"}},{"id":4145131,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Options (right to buy)","published_at":"2017-12-05T01:00:29.000Z","date":"2017-11-30","kind":"exercise","acquired":false,"shares":6667,"price":7.38,"value":49202.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $55.93, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above."}],"balance_after":0,"derivative":{"exercise_price":7.38,"exercise_date":"2009-07-23","expiration_date":"2018-07-23","underlying":"Common Stock","underlying_shares":6667},"source":{"system":"sec-edgar","filing":"0001209191-17-063683","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117063683/doc4.xml","form_type":"4"}},{"id":4145130,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T01:00:29.000Z","date":"2017-11-30","kind":"sale","acquired":false,"shares":6667,"price":55.89,"value":372618.63,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $55.93, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above."}],"balance_after":6666,"source":{"system":"sec-edgar","filing":"0001209191-17-063683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117063683/doc4.xml","form_type":"4"}},{"id":4145129,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-05T01:00:29.000Z","date":"2017-11-30","kind":"exercise","acquired":true,"shares":6667,"price":7.38,"value":49202.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.87 to $55.93, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth above."}],"balance_after":13333,"source":{"system":"sec-edgar","filing":"0001209191-17-063683","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117063683/doc4.xml","form_type":"4"}},{"id":4387335,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-03-15T01:46:59.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest at a rate of 1/24th of the total option amount granted on a monthly basis over two years commencing on the first monthly anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":12350,"derivative":{"exercise_price":32.63,"expiration_date":"2027-03-10","underlying":"Common Stock","underlying_shares":12350},"source":{"system":"sec-edgar","filing":"0001209191-17-020687","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020687/doc4.xml","form_type":"4"}},{"id":4387334,"issuer":{"id":4426,"kind":"organization","name":"Sarepta Therapeutics, Inc.","symbol":"SRPT"},"owners":[{"id":41122,"kind":"person","name":"Wigzell Hans Lennart Rudolf","position":1,"cik":"0001492766","reported_name":"Wigzell Hans Lennart Rudolf","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-15T01:46:59.000Z","date":"2017-03-10","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents the right to receive one share of common stock and will vest in full on the first year anniversary of Sarepta's 2017 Annual Meeting of Stockholders."}],"balance_after":6666,"source":{"system":"sec-edgar","filing":"0001209191-17-020687","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/873303/000120919117020687/doc4.xml","form_type":"4"}}]}